These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 29668746)

  • 21. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
    Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
    Trials; 2010 Oct; 11():97. PubMed ID: 20942940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
    Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A
    Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Amount of Mitochondrial DNA in Blood Reflects the Course of a Depressive Episode.
    Nicod J; Wagner S; Vonberg F; Bhomra A; Schlicht KF; Tadic A; Mott R; Lieb K; Flint J
    Biol Psychiatry; 2016 Sep; 80(6):e41-e42. PubMed ID: 26917357
    [No Abstract]   [Full Text] [Related]  

  • 25. Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.
    Tadić A; Wachtlin D; Berger M; Braus DF; van Calker D; Dahmen N; Dreimüller N; Engel A; Gorbulev S; Helmreich I; Kaiser AK; Kronfeld K; Schlicht KF; Tüscher O; Wagner S; Hiemke C; Lieb K
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):705-16. PubMed ID: 26899588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Rosenblat JD; Kakar R; McIntyre RS
    Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches.
    Snyder HR; Miyake A; Hankin BL
    Front Psychol; 2015; 6():328. PubMed ID: 25859234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review.
    Bortolato B; Carvalho AF; McIntyre RS
    CNS Neurol Disord Drug Targets; 2014; 13(10):1804-18. PubMed ID: 25470396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.
    Snyder HR
    Psychol Bull; 2013 Jan; 139(1):81-132. PubMed ID: 22642228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment.
    Wagner S; Doering B; Helmreich I; Lieb K; Tadić A
    Acta Psychiatr Scand; 2012 Apr; 125(4):281-92. PubMed ID: 22007857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study.
    Hinkelmann K; Moritz S; Botzenhardt J; Muhtz C; Wiedemann K; Kellner M; Otte C
    Psychoneuroendocrinology; 2012 May; 37(5):685-92. PubMed ID: 21944955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.
    Beblo T; Sinnamon G; Baune BT
    Neuropsychol Rev; 2011 Dec; 21(4):337-59. PubMed ID: 21660503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of three alternate forms of the trail making tests a and B.
    Wagner S; Helmreich I; Dahmen N; Lieb K; Tadic A
    Arch Clin Neuropsychol; 2011 Jun; 26(4):314-21. PubMed ID: 21576092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder.
    Tadić A; Wagner S; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Lieb K
    BMC Psychiatry; 2011 Jan; 11():16. PubMed ID: 21269443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized rater training for the Hamilton Depression Rating Scale (HAMD₁₇) and the Inventory of Depressive Symptoms (IDS(C30)).
    Wagner S; Helmreich I; Lieb K; Tadić A
    Psychopathology; 2011; 44(1):68-70. PubMed ID: 21072002
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.
    Herrera-Guzmán I; Herrera-Abarca JE; Gudayol-Ferré E; Herrera-Guzmán D; Gómez-Carbajal L; Peña-Olvira M; Villuendas-González E; Joan GO
    Psychiatry Res; 2010 May; 177(3):323-9. PubMed ID: 20385412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial.
    Tadić A; Gorbulev S; Dahmen N; Hiemke C; Braus DF; Röschke J; van Calker D; Wachtlin D; Kronfeld K; Gorbauch T; Seibert-Grafe M; Lieb K;
    Trials; 2010 Feb; 11():21. PubMed ID: 20187947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new paradigm for the prediction of antidepressant treatment response.
    Leuchter AF; Cook IA; Hunter AM; Korb AS
    Dialogues Clin Neurosci; 2009; 11(4):435-46. PubMed ID: 20135901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enduring cognitive dysfunction in unipolar major depression: a test-retest study using the Stroop paradigm.
    Hammar A; Sørensen L; Ardal G; Oedegaard KJ; Kroken R; Roness A; Lund A
    Scand J Psychol; 2010 Aug; 51(4):304-8. PubMed ID: 20042028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients.
    Szegedi A; Jansen WT; van Willigenburg AP; van der Meulen E; Stassen HH; Thase ME
    J Clin Psychiatry; 2009 Mar; 70(3):344-53. PubMed ID: 19254516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.